Back
No evidence for the presence and control of tumor growth by cytoplasmic stress granules in pancreatic cancer
Libert, M.; Fain, J.; Bouchart, C.; Arsenijevic, T.; Van Laethem, J.-L.; Jacquemin, P.
2023-11-15
cancer biology
10.1101/2023.11.13.566518
bioRxiv
Show abstract
Cytoplasmic stress granules (SG) are attracting growing attention in cancer research1. As such, a study published in Cell2 has certainly served as a trigger for this trend which currently asserts that SG are a relevant therapeutic target. Here, we would like to express a warning about the conclusions of this article, as well as of the subsequent study3, and more generally on a methodological approach frequently used in research studying SG in cancer and which we believe to be misleading.
Matching journals
●Non-profit
◐University press
○Commercial
The top 15 journals account for 50% of the predicted probability mass.
2
Scientific Reports
○
3612 papers in training set
Top 9%
6.8%
Similar papers in this journal
3
PLOS ONE
●
5266 papers in training set
Top 31%
4.4%
Similar papers in this journal
- MG53 is not a critical regulator of insulin signaling pathway in skeletal muscle 91%
- Blockade of Interleukin-6 (IL-6) Signaling in Dedifferentiated Liposarcoma (DDLPS) Decreases Mouse Double Minute 2 (MDM2) Oncogenicity via Alternative Splicing 91%
- Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction. 90%
4
eLife
●
5828 papers in training set
Top 30%
4.1%
Similar papers in this journal
- Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis 93%
- Bestrophin-4 relays Hes4 and interacts with Twist1 to suppress epithelial-to-mesenchymal transition in colorectal cancer cells 92%
- Single cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree 91%
5
Molecular Oncology
○
55 papers in training set
Top 0.2%
3.3%
Similar papers in this journal
- MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation 91%
- RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venues 91%
- Inhibition of Acyl-CoA Synthetase Long Chain Isozymes Decreases Multiple Myeloma Cell Proliferation and Causes Mitochondrial Dysfunction 90%
50% of probability mass above